Lee-Sherick et al. demonstrated that mice treated with a small molecule MERTK inhibitor not only had decreased numbers of B-ALL leukemia cells in their spleen and bone marrow, but also showed prolonged survival compared to their vehicle-treated control counterparts [71]. Here, MERTK is linked to leukemia.